(Boursier.com) — TheraVet launches BIOCERA-VET Equine in countries already covered by the Company.
Having been evaluated by equine veterinarians in orthopedic and dental applications over the last 12 months, BIOCERA-VET is now available on the market with 2 additional references (3cc and 6cc) specifically adapted in terms of volume and devices to the applications equines.
BIOCERA-VE(R) has an exclusive positioning in the treatment of subchondral bone cysts, thanks to the properties required for minimally invasive cementoplasty (high injectability, great workability, high radiopacity, strong cohesion and rapid setting).
©2024 Boursier.com